Line 1: |
Line 1: |
− | ==Forewords and Introductions[[chapter['chapterTitle'|Overview Page Link]]== | + | ==Forewords and Introductions[[Forewords and Introductions|Overview Page Link]]== |
− | - [[General Introduction]]
| + | ==Myeloid proliferations and neoplasms[[Myeloid proliferations and neoplasms|Overview Page Link]]== |
− | - [[ICCR datasets: Haemopoietic]]
| |
− | ==Myeloid proliferations and neoplasms[[chapter['chapterTitle'|Overview Page Link]]== | |
| ===Myeloid precursor lesions=== | | ===Myeloid precursor lesions=== |
| ''Clonal Haematopoiesis'' | | ''Clonal Haematopoiesis'' |
− | - [[Introduction]]
| |
| - [[Clonal haematopoiesis]] | | - [[Clonal haematopoiesis]] |
| - [[Clonal cytopenias of undetermined significance]] | | - [[Clonal cytopenias of undetermined significance]] |
| ===Myeloproliferative neoplasms=== | | ===Myeloproliferative neoplasms=== |
| ''Myeloproliferative neoplasms'' | | ''Myeloproliferative neoplasms'' |
− | - [[Introduction]]
| |
| - [[Chronic myeloid leukaemia]] | | - [[Chronic myeloid leukaemia]] |
| - [[Chronic neutrophilic leukaemia]] | | - [[Chronic neutrophilic leukaemia]] |
Line 20: |
Line 16: |
| - [[Myeloproliferative neoplasm, NOS]] | | - [[Myeloproliferative neoplasm, NOS]] |
| ===Mastocytosis=== | | ===Mastocytosis=== |
− | - [[Introduction]]
| |
| - [[Cutaneous mastocytosis]] | | - [[Cutaneous mastocytosis]] |
| - [[Systemic mastocytosis]] | | - [[Systemic mastocytosis]] |
| - [[Mast cell sarcoma]] | | - [[Mast cell sarcoma]] |
| ===Myelodysplastic neoplasms=== | | ===Myelodysplastic neoplasms=== |
− | - [[Introduction]]
| |
| ''Myelodysplastic neoplasms, with defining genetic abnormalities'' | | ''Myelodysplastic neoplasms, with defining genetic abnormalities'' |
| - [[Myelodysplastic neoplasm with low blasts and 5q deletion]] | | - [[Myelodysplastic neoplasm with low blasts and 5q deletion]] |
Line 38: |
Line 32: |
| - [[Childhood myelodysplastic neoplasm with increased blasts]] | | - [[Childhood myelodysplastic neoplasm with increased blasts]] |
| ===Myelodysplastic/myeloproliferative neoplasms=== | | ===Myelodysplastic/myeloproliferative neoplasms=== |
− | - [[Introduction]]
| |
| - [[Chronic myelomonocytic leukaemia]] | | - [[Chronic myelomonocytic leukaemia]] |
| - [[Myelodysplastic/myeloproliferative neoplasm with neutrophilia]] | | - [[Myelodysplastic/myeloproliferative neoplasm with neutrophilia]] |
Line 44: |
Line 37: |
| - [[Myelodysplastic/myeloproliferative neoplasm, NOS]] | | - [[Myelodysplastic/myeloproliferative neoplasm, NOS]] |
| ===Acute myeloid leukaemia=== | | ===Acute myeloid leukaemia=== |
− | - [[Introduction]]
| |
| ''Acute myeloid leukaemia with defining genetic abnormalities'' | | ''Acute myeloid leukaemia with defining genetic abnormalities'' |
| - [[Acute promyelocytic leukaemia with PML::RARA fusion]] | | - [[Acute promyelocytic leukaemia with PML::RARA fusion]] |
Line 72: |
Line 64: |
| ===Myeloid neoplasms, secondary=== | | ===Myeloid neoplasms, secondary=== |
| ''Myeloid neoplasms and proliferations associated with antecedent or predisposing conditions'' | | ''Myeloid neoplasms and proliferations associated with antecedent or predisposing conditions'' |
− | - [[Introduction]]
| |
| - [[Myeloid neoplasm post cytotoxic therapy]] | | - [[Myeloid neoplasm post cytotoxic therapy]] |
| - [[Myeloid neoplasms associated with germline predisposition]] | | - [[Myeloid neoplasms associated with germline predisposition]] |
Line 78: |
Line 69: |
| ===Myeloid/lymphoid neoplasms=== | | ===Myeloid/lymphoid neoplasms=== |
| ''Myeloid/lymphoid neoplasms with eosinophilia and defining gene rearrangement'' | | ''Myeloid/lymphoid neoplasms with eosinophilia and defining gene rearrangement'' |
− | - [[Introduction]]
| |
| - [[Myeloid/lymphoid neoplasm with PDGFRA rearrangement]] | | - [[Myeloid/lymphoid neoplasm with PDGFRA rearrangement]] |
| - [[Myeloid/lymphoid neoplasm with PDGFRB rearrangement]] | | - [[Myeloid/lymphoid neoplasm with PDGFRB rearrangement]] |
Line 87: |
Line 77: |
| - [[Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes]] | | - [[Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes]] |
| ===Acute leukaemias of mixed or ambiguous lineage=== | | ===Acute leukaemias of mixed or ambiguous lineage=== |
− | - [[Introduction]]
| |
| ''Acute leukaemia of ambiguous lineage with defining genetic abnormalities'' | | ''Acute leukaemia of ambiguous lineage with defining genetic abnormalities'' |
| - [[Mixed-phenotype acute leukaemia with BCR::ABL1 fusion]] | | - [[Mixed-phenotype acute leukaemia with BCR::ABL1 fusion]] |
Line 98: |
Line 87: |
| - [[Acute leukaemia of ambiguous lineage, NOS]] | | - [[Acute leukaemia of ambiguous lineage, NOS]] |
| - [[Acute undifferentiated leukaemia]] | | - [[Acute undifferentiated leukaemia]] |
− | ==Histiocytic/Dendritic cell neoplasms[[chapter['chapterTitle'|Overview Page Link]]== | + | ==Histiocytic/Dendritic cell neoplasms[[Histiocytic/Dendritic cell neoplasms|Overview Page Link]]== |
− | - [[Introduction]]
| |
| ===Plasmacytoid dendritic cell neoplasms=== | | ===Plasmacytoid dendritic cell neoplasms=== |
| ''Plasmacytoid dendritic cell neoplasms'' | | ''Plasmacytoid dendritic cell neoplasms'' |
Line 118: |
Line 106: |
| - [[ALK-positive histiocytosis]] | | - [[ALK-positive histiocytosis]] |
| - [[Histiocytic sarcoma]] | | - [[Histiocytic sarcoma]] |
− | ==B-cell lymphoid proliferations and lymphomas[[chapter['chapterTitle'|Overview Page Link]]== | + | ==B-cell lymphoid proliferations and lymphomas[[B-cell lymphoid proliferations and lymphomas|Overview Page Link]]== |
− | - [[Introduction to B-cell lymphoproliferative disorders and neoplasms]]
| |
| ===Tumour like lesions with B-cell predominance=== | | ===Tumour like lesions with B-cell predominance=== |
− | - [[Introduction]]
| |
| - [[Reactive B-cell rich lymphoid proliferations that can mimic lymphoma]] | | - [[Reactive B-cell rich lymphoid proliferations that can mimic lymphoma]] |
| - [[IgG4-related disease]] | | - [[IgG4-related disease]] |
Line 129: |
Line 115: |
| ===Precursor B-cell neoplasms=== | | ===Precursor B-cell neoplasms=== |
| ''B-lymphoblastic leukaemias/lymphomas'' | | ''B-lymphoblastic leukaemias/lymphomas'' |
− | - [[Introduction]]
| |
| - [[B-lymphoblastic leukaemia/lymphoma]] | | - [[B-lymphoblastic leukaemia/lymphoma]] |
| - [[B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy]] | | - [[B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy]] |
Line 146: |
Line 131: |
| ===Mature B-cell neoplasms=== | | ===Mature B-cell neoplasms=== |
| ''Pre-neoplastic and neoplastic small lymphocytic proliferations '' | | ''Pre-neoplastic and neoplastic small lymphocytic proliferations '' |
− | - [[Introduction]]
| |
| - [[Monoclonal B-cell lymphocytosis]] | | - [[Monoclonal B-cell lymphocytosis]] |
| - [[Chronic lymphocytic leukaemia/small lymphocytic lymphoma]] | | - [[Chronic lymphocytic leukaemia/small lymphocytic lymphoma]] |
| ''Splenic B-cell lymphomas and leukaemias'' | | ''Splenic B-cell lymphomas and leukaemias'' |
− | - [[Introduction]]
| |
| - [[Hairy cell leukaemia]] | | - [[Hairy cell leukaemia]] |
| - [[Splenic marginal zone lymphoma]] | | - [[Splenic marginal zone lymphoma]] |
Line 158: |
Line 141: |
| - [[Lymphoplasmacytic lymphoma]] | | - [[Lymphoplasmacytic lymphoma]] |
| ''Marginal zone lymphoma'' | | ''Marginal zone lymphoma'' |
− | - [[Introduction]]
| |
| - [[Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue]] | | - [[Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue]] |
| - [[Primary cutaneous marginal zone lymphoma ]] | | - [[Primary cutaneous marginal zone lymphoma ]] |
Line 164: |
Line 146: |
| - [[Paediatric nodal marginal zone lymphoma]] | | - [[Paediatric nodal marginal zone lymphoma]] |
| ''Follicular lymphoma'' | | ''Follicular lymphoma'' |
− | - [[Introduction]]
| |
| - [[In situ follicular B-cell neoplasm]] | | - [[In situ follicular B-cell neoplasm]] |
| - [[Follicular lymphoma]] | | - [[Follicular lymphoma]] |
Line 172: |
Line 153: |
| - [[Primary cutaneous follicle centre lymphoma]] | | - [[Primary cutaneous follicle centre lymphoma]] |
| ''Mantle cell lymphoma'' | | ''Mantle cell lymphoma'' |
− | - [[Introduction]]
| |
| - [[In situ mantle cell neoplasm]] | | - [[In situ mantle cell neoplasm]] |
| - [[Mantle cell lymphoma]] | | - [[Mantle cell lymphoma]] |
| - [[Leukaemic non-nodal mantle cell lymphoma]] | | - [[Leukaemic non-nodal mantle cell lymphoma]] |
| ''Transformations of indolent B-cell lymphomas'' | | ''Transformations of indolent B-cell lymphomas'' |
− | - [[Introduction]]
| |
| - [[Transformations of indolent B-cell lymphomas]] | | - [[Transformations of indolent B-cell lymphomas]] |
| ''Large B-cell lymphomas'' | | ''Large B-cell lymphomas'' |
− | - [[Introduction]]
| |
| - [[Diffuse large B-cell lymphoma, NOS]] | | - [[Diffuse large B-cell lymphoma, NOS]] |
| - [[T-cell/histiocyte-rich large B-cell lymphoma]] | | - [[T-cell/histiocyte-rich large B-cell lymphoma]] |
Line 202: |
Line 180: |
| - [[Burkitt lymphoma]] | | - [[Burkitt lymphoma]] |
| ''KSHV/HHV8-associated B-cell lymphoid proliferations and lymphomas'' | | ''KSHV/HHV8-associated B-cell lymphoid proliferations and lymphomas'' |
− | - [[Introduction]]
| |
| - [[Primary effusion lymphoma]] | | - [[Primary effusion lymphoma]] |
| - [[KSHV/HHV8-positive diffuse large B-cell lymphoma]] | | - [[KSHV/HHV8-positive diffuse large B-cell lymphoma]] |
| - [[KSHV/HHV8-positive germinotropic lymphoproliferative disorder]] | | - [[KSHV/HHV8-positive germinotropic lymphoproliferative disorder]] |
| ''Lymphoid proliferations and lymphomas associated with immune deficiency and dysregulation'' | | ''Lymphoid proliferations and lymphomas associated with immune deficiency and dysregulation'' |
− | - [[Introduction]]
| |
| - [[Hyperplasias arising in immune deficiency/dysregulation]] | | - [[Hyperplasias arising in immune deficiency/dysregulation]] |
| - [[Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation ]] | | - [[Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation ]] |
Line 214: |
Line 190: |
| - [[Inborn error of immunity-associated lymphoid proliferations and lymphomas]] | | - [[Inborn error of immunity-associated lymphoid proliferations and lymphomas]] |
| ===Hodgkin lymphoma=== | | ===Hodgkin lymphoma=== |
− | - [[Introduction]]
| |
| - [[Classic Hodgkin lymphoma ]] | | - [[Classic Hodgkin lymphoma ]] |
| - [[Nodular lymphocyte predominant Hodgkin lymphoma]] | | - [[Nodular lymphocyte predominant Hodgkin lymphoma]] |
| ===Plasma cell neoplasms and other diseases with paraproteins=== | | ===Plasma cell neoplasms and other diseases with paraproteins=== |
− | - [[Introduction]]
| |
| ''Monoclonal gammopathies'' | | ''Monoclonal gammopathies'' |
| - [[Cold agglutinin disease ]] | | - [[Cold agglutinin disease ]] |
Line 228: |
Line 202: |
| - [[Monoclonal immunoglobulin deposition disease]] | | - [[Monoclonal immunoglobulin deposition disease]] |
| ''Heavy chain diseases'' | | ''Heavy chain diseases'' |
− | - [[Introduction]]
| |
| - [[Mu heavy chain disease]] | | - [[Mu heavy chain disease]] |
| - [[Gamma heavy chain disease]] | | - [[Gamma heavy chain disease]] |
| - [[Alpha heavy chain disease]] | | - [[Alpha heavy chain disease]] |
| ''Plasma cell neoplasms'' | | ''Plasma cell neoplasms'' |
− | - [[Introduction]]
| |
| - [[Plasmacytoma]] | | - [[Plasmacytoma]] |
| - [[Plasma cell myeloma / multiple myeloma]] | | - [[Plasma cell myeloma / multiple myeloma]] |
| - [[Plasma cell neoplasms with associated paraneoplastic syndrome]] | | - [[Plasma cell neoplasms with associated paraneoplastic syndrome]] |
− | ==T-cell and NK-cell lymphoid proliferations and lymphomas [[chapter['chapterTitle'|Overview Page Link]]== | + | ==T-cell and NK-cell lymphoid proliferations and lymphomas [[T-cell and NK-cell lymphoid proliferations and lymphomas |Overview Page Link]]== |
− | - [[Introduction]]
| |
| ===Tumour-like lesions with T-cell predominance=== | | ===Tumour-like lesions with T-cell predominance=== |
| - [[Kikuchi-Fujimoto disease]] | | - [[Kikuchi-Fujimoto disease]] |
Line 249: |
Line 220: |
| ===Mature T-cell and NK-cell neoplasms=== | | ===Mature T-cell and NK-cell neoplasms=== |
| ''Mature T-cell and NK-cell leukaemias'' | | ''Mature T-cell and NK-cell leukaemias'' |
− | - [[Introduction]]
| |
| - [[T-prolymphocytic leukaemia]] | | - [[T-prolymphocytic leukaemia]] |
| - [[T-large granular lymphocytic leukaemia]] | | - [[T-large granular lymphocytic leukaemia]] |
| + | - [[NK-large granular lymphocytic leukaemia]] |
| + | - [[Adult T-cell leukaemia/lymphoma]] |
| + | - [[Sezary syndrome]] |
| + | - [[Aggressive NK-cell leukaemia]] |
| + | ''Primary cutaneous T-cell lymphoid proliferations and lymphomas'' |
| + | - [[Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder]] |
| + | - [[Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder]] |
| + | - [[Mycosis fungoides]] |
| + | - [[Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis]] |
| + | - [[Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma]] |
| + | - [[Subcutaneous panniculitis-like T-cell lymphoma]] |
| + | - [[Primary cutaneous gamma/delta T-cell lymphoma]] |
| + | - [[Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma]] |
| + | - [[Primary cutaneous peripheral T-cell lymphoma, NOS]] |
| + | ''Intestinal T-cell and NK-cell lymphoid proliferations and lymphomas'' |
| + | - [[Indolent T-cell lymphoma of the gastrointestinal tract]] |
| + | - [[Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract]] |
| + | - [[Enteropathy-associated T-cell lymphoma]] |
| + | - [[Monomorphic epitheliotropic intestinal T-cell lymphoma]] |
| + | - [[Intestinal T-cell lymphoma, NOS]] |
| + | ''Hepatosplenic T-cell lymphoma'' |
| + | - [[Hepatosplenic T-cell lymphoma]] |
| + | ''Anaplastic large cell lymphoma'' |
| + | - [[ALK-positive anaplastic large cell lymphoma]] |
| + | - [[ALK-negative anaplastic large cell lymphoma]] |
| + | - [[Breast implant-associated anaplastic large cell lymphoma]] |
| + | ''Nodal T-follicular helper (TFH) cell lymphoma'' |
| + | - [[Nodal TFH cell lymphoma, angioimmunoblastic-type]] |
| + | - [[Nodal TFH cell lymphoma, follicular-type]] |
| + | - [[Nodal TFH cell lymphoma, NOS]] |
| + | ''Other peripheral T-cell lymphomas'' |
| + | - [[Peripheral T-cell lymphoma, NOS]] |
| + | ''EBV-positive NK-cell and T-cell lymphomas'' |
| + | - [[EBV-positive nodal T- and NK-cell lymphoma]] |
| + | - [[Extranodal NK/T-cell lymphoma]] |
| + | ''EBV-positive T-cell and NK-cell lymphoid proliferations and lymphomas of childhood'' |
| + | - [[Severe mosquito bite allergy]] |
| + | - [[Hydroa vacciniforme lymphoproliferative disorder]] |
| + | - [[Systemic chronic active EBV disease]] |
| + | - [[Systemic EBV-positive T-cell lymphoma of childhood]] |
| + | ==Stroma-derived neoplasms of lymphoid tissues[[Stroma-derived neoplasms of lymphoid tissues|Overview Page Link]]== |
| + | ===Mesenchymal dendritic cell neoplasms=== |
| + | ''Follicular dendritic cell neoplasms'' |
| + | - [[Follicular dendritic cell sarcoma]] |
| + | - [[EBV-positive inflammatory follicular dendritic cell sarcoma]] |
| + | - [[Fibroblastic reticular cell tumour]] |
| + | ===Myofibroblastic tumours=== |
| + | ''Myofibroblastic tumour'' |
| + | - [[Intranodal palisaded myofibroblastoma]] |
| + | ===Spleen-specific vascular-stromal tumours=== |
| + | ''Splenic vascular-stromal tumours'' |
| + | - [[Littoral cell angioma]] |
| + | - [[Splenic hamartoma]] |
| + | - [[Sclerosing angiomatoid nodular transformation (SANT) of spleen]] |
| + | ==Genetic tumour syndromes[[Genetic tumour syndromes|Overview Page Link]]== |
| + | - [[Fanconi anaemia]] |
| + | - [[Bloom syndrome]] |
| + | - [[Ataxia-telangiectasia syndrome]] |
| + | - [[RASopathies]] |